Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

拉米夫定替诺福韦片 - NMPA Drug Approval Details

Approvals/NMPA/Lamivudine and Tenofovir disoproxil fumarate Tablets

Approved

化学药品

Lamivudine and Tenofovir disoproxil fumarate Tablets

上海迪赛诺医药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 25, 2024
Approval ID: 8gJy3O8t7LC
Company: 上海迪赛诺医药集团股份有限公司
Type: 化学药品

Approval Details

Approval Id: 8gJy3O8t7LC
Approval Number: 国药准字H20249842
Generic Name: 拉米夫定替诺福韦片
Generic Name En: Lamivudine and Tenofovir disoproxil fumarate Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含拉米夫定300mg和富马酸替诺福韦二吡呋酯300mg
Reg Date: 2024-12-25
Company Name: 上海迪赛诺医药集团股份有限公司
Company Address: 中国（上海）自由贸易试验区张衡路1479号1幢
Production Company Name: 江苏诚康药业有限公司
Production Company Address: 江苏大丰盐土大地海洋生物产业科技园
Company Detail Path: /organization/47298f715521b5ab/shang-hai-di-sai-nuo-yi-yao-ji-tuan-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/abce700c59dcb4fa/jiang-su-cheng-kang-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 25, 2024

Approval ID

8gJy3O8t7LC

Type

化学药品

Back to NMPA Approvals